Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
7.49
+0.02 (0.27%)
Feb 2, 2026, 1:39 PM EST - Market open
ARCT Revenue
Arcturus Therapeutics Holdings had revenue of $17.15M in the quarter ending September 30, 2025, a decrease of -58.84%. This brings the company's revenue in the last twelve months to $97.60M, down -39.15% year-over-year. In the year 2024, Arcturus Therapeutics Holdings had annual revenue of $152.31M, down -8.69%.
Revenue (ttm)
$97.60M
Revenue Growth
-39.15%
P/S Ratio
2.08
Revenue / Employee
$554,551
Employees
176
Market Cap
212.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 152.31M | -14.49M | -8.69% |
| Dec 31, 2023 | 166.80M | -39.20M | -19.03% |
| Dec 31, 2022 | 206.00M | 193.64M | 1,566.79% |
| Dec 31, 2021 | 12.36M | 2.82M | 29.56% |
| Dec 31, 2020 | 9.54M | -11.25M | -54.12% |
| Dec 31, 2019 | 20.79M | 5.04M | 31.97% |
| Dec 31, 2018 | 15.75M | 2.76M | 21.20% |
| Dec 31, 2017 | 13.00M | -7.38M | -36.23% |
| Dec 31, 2016 | 20.38M | 14.24M | 232.06% |
| Dec 31, 2015 | 6.14M | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alector | 69.05M |
| Voyager Therapeutics | 31.32M |
| Silence Therapeutics | 25.83M |
| Tonix Pharmaceuticals Holding | 10.30M |
| Ovid Therapeutics | 6.61M |
| SAB Biotherapeutics | 114.70K |
| Inhibikase Therapeutics | 1.00 |
ARCT News
- 24 days ago - Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - Arcturus Therapeutics to Attend Upcoming Investor Conference - Business Wire
- 2 months ago - Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress - Business Wire
- 3 months ago - Arcturus Therapeutics to Attend Upcoming Investor Conferences - Business Wire
- 3 months ago - Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025 - Business Wire
- 3 months ago - Arcturus' Investigational Inhaled Therapy Lacks Meaningful Lung Function Improvement, Analyst Notes Mixed Picture - Benzinga
- 3 months ago - Arcturus Therapeutics shares plunge 56% after mixed phase 2 CF drug results - Invezz